Abstract
Objective: Several studies indicate that in utero exposure to maternal autoimmune diseases and
transplacental passage of autoantibodies affect the risk of autoimmunity in the offspring,
e. g., maternally derived GAD65 autoantibody correlates with decreased risk of type
1 diabetes, whereas thyroid peroxidase autoantibody (TPOAb) positivity at birth is
associated with increased incidence of autoimmune thyroid disease later in life. The
aim of this study was to identify immunological changes in children born to mothers
with thyroid autoimmunity that may be related to in utero exposure to autoantibodies.
Design and method: Open label prospective analysis of cord blood lymphocytes and serum cytokines by
Flow Cytometry in children born to mothers with autoimmune thyroiditis (AIT) (n=31)
and to healthy mothers (n=76) and titers of thyroid autoantibodies were determined
in cord blood and in maternal peripheral blood at delivery.
Results: We found an increase (almost 30%) in the frequency of cord blood natural killer (NK)
cells (p=0.0016) and a minor increase in the subset of T cells expressing NK markers
(p=0.028), in children born to AIT mothers. There were no detectable differences in
the phenotype or frequency of cord blood memory/activated T cells, including CD4+ CD25+ T cells, between the 2 groups. The levels of pro-inflammatory cytokines TNF-α, IL-10,
IL-12p70, IFN-γ and IL-1β were significantly decreased in offspring of AIT mothers
as compared to healthy controls.
Conclusions: Maternal thyroid autoimmunity and transplacental passage of autoantibodies against
thyroid antigens may affect the generation or expansion of cells with NK activity
and the secretion of inflammatory cytokines.
Key words
cord blood - lymphocyte subsets - NK cells - regulatory T cells - cytokine - autoimmune
thyroid diseases - type 1 diabetes
References
1
Balmelli C, Vincent IE, Rau H. et al .
Fc gamma RII-dependent sensitisation of natural interferon-producing cells for viral
infection and interferon-alpha responses.
Eur J Immunol.
2005;
35
2406-2415
2 Brawerman LE UR. The Thyroid, 8th Edition. Philadelphia, New York: Lippincott-Raven
Publishers; 2000
3
Caturegli P, Kimura H, Rocchi R. et al .
Autoimmune thyroid diseases.
Curr Opin Rheumatol.
2007;
19
44-48
4
Dahlquist G, Blom L, Lonnberg G.
The Swedish Childhood Diabetes Study – a multivariate analysis of risk determinants
for diabetes in different age groups.
Diabetologia.
1991;
34
757-762
5
Fonteneau JF, Larsson M, Beignon AS. et al .
Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly
induces the bystander maturation of myeloid dendritic cells.
J Virol.
2004;
78
5223-5232
6
Gerosa F, Gobbi A, Zorzi P. et al .
The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells
profoundly affects innate resistance functions.
J Immunol.
2005;
174
727-734
7
Greeley SA, Katsumata M, Yu L. et al .
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese
diabetic mice.
Nat Med.
2002;
8
399-402
8
Hanson LA, Korotkova M, Lundin S. et al .
The transfer of immunity from mother to child.
Ann NY Acad Sci.
2003;
987
199-206
9
Hidaka Y, Amino N, Iwatani Y. et al .
Increase in peripheral natural killer cell activity in patients with autoimmune thyroid
disease.
Autoimmunity.
1992;
11
239-246
10
Holm BC, Svensson J, Akesson C. et al .
Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood
T cells in children born to mothers with type 1 diabetes.
Clin Exp Immunol.
2006;
146
493-502
11
Jego G, Palucka AK, Blanck JP. et al .
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon
and interleukin 6.
Immunity.
2003;
19
225-234
12
Koczwara K, Bonifacio E, Ziegler AG.
Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring
of mothers with type 1 diabetes.
Diabetes.
2004;
53
1-4
13
Kvetny J, Poulsen H.
Transient hyperthyroxinemia in newborns from women with autoimmune thyroid disease
and raised levels of thyroid peroxidase antibodies.
J Matern Fetal Neonatal Med.
2006;
19
817-822
14
Lee LA.
Transient autoimmunity related to maternal autoantibodies: neonatal lupus.
Autoimmun Rev.
2005;
4
207-213
15
Linder N, Taushtein I, Handsher R. et al .
Placental transfer of maternal poliovirus antibodies in full-term and pre-term infants.
Vaccine.
1998;
16
236-239
16
Linder N, Sirota L, Aboudy Y. et al .
Placental transfer of maternal rubella antibodies to full-term and preterm infants.
Infection.
1999;
27
203-207
17
Lovgren T, Eloranta ML, Kastner B. et al .
Induction of interferon-alpha by immune complexes or liposomes containing systemic
lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA.
Arthritis Rheum.
2006;
54
1917-1927
18
Luton D, Le Gac I, Vuillard E. et al .
Management of Graves' disease during pregnancy: the key role of fetal thyroid gland
monitoring.
J Clin Endocr Metab.
2005;
90
6093-6098
19
Meyers JA, Mangini AJ, Nagai T. et al .
Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine
IFN-gamma and IL-17 secretion by activated human PBMC.
Cytokine.
2006;
35
235-246
20
Polak M.
Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with
a focus on neonatal hyperthyroidism.
Thyroid.
1998;
8
1171-1177
21
Romagnani C, Della Chiesa M, Kohler S. et al .
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by
CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
Eur J Immunol.
2005;
35
2452-2458
22
Solerte SB, Precerutti S, Gazzaruso C. et al .
Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's
thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Eur J Endocrinol.
2005;
152
703-712
23
Svensson J, Lindberg B, Jonsson B. et al .
Intrauterine exposure to maternal enterovirus infection as a risk factor for development
of autoimmune thyroiditis during childhood and adolescence.
Thyroid.
2004;
14
367-370
24
Svensson J, Lindberg B, Ericsson UB. et al .
Thyroid autoantibodies in cord blood sera from children and adolescents with autoimmune
thyroiditis.
Thyroid.
2006;
16
79-83
25
Tincani A, Rebaioli CB, Frassi M. et al .
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy
outcome.
Autoimmun Rev.
2005;
4
423-428
26
Tincani A, Bompane D, Danieli E. et al .
Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome).
Lupus.
2006;
15
156-160
27
Warram JH, Martin BC, Krolewski AS.
Risk of IDDM in children of diabetic mothers decreases with increasing maternal age
at pregnancy.
Diabetes.
1991;
40
1679-1684
28
Wenzel BE, Chow A, Baur R. et al .
Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Thyroid.
1998;
8
1019-1022
29
Zou W, Borvak J, Wei S. et al .
Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection.
Eur J Immunol.
2001;
31
3833-3839
1 These authors contributed equally to this work.
Correspondence
M. LantzMD, PhD
Department of Endocrinology
Malmö University Hospital
20502 Malmö
Sweden
Phone: + 46/708/202 315
Fax: + 46/337/004
Email: Mikael.Lantz@med.lu.se